Suppr超能文献

[牡丹皮原植物及药材质量研究]

[Research on the quality of original plants and material medicine of Cortex Paeoniae].

作者信息

Guo Bao-lin, Basang Deji, Xiao Pei-gen, Hong De-yuan

机构信息

Institute of Medicinal Plant, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100094, China.

出版信息

Zhongguo Zhong Yao Za Zhi. 2002 Sep;27(9):654-7.

Abstract

OBJECTIVE

To study the contents of main chemical compounds, such as, paeonol, paeoniflorin and their similar compounds in structure in Paeonia ostii and P. suffruticosa, and to find their quality difference.

METHOD

HPLC was used. The contents of paeoniflorin and paeonol in 9 collected samples, 5 from P. ostii and 4 from P. suffruticosa, and 6 herb samples bought from different areas were analyzed. The rough contents of 3 paeonol similar compounds and 2 paeoniflorin similar compounds were investigated.

RESULT AND CONCLUSION

  1. There is no obvious difference in the contents of paeonol and paeonoflorin and the constitution of other main compounds between P. ostii and P. suffruticosa. Since they belong to different botanic species, it is suggested that both P. ostii and P. suffruticosa should be recorded in Chinese Pharmacopoeia as the origin of Cortex Paeoniae. 2. The glucosides of paeonol might change to paeonol in the course of the collecting and processing of the herb. Therefore when the contents of paeonol is used as the standard to evaluate the quality of the material and patent medicine, the attention should be paid to the transformation mentioned above.
摘要

目的

研究凤丹和牡丹中主要化学成分如丹皮酚、芍药苷及其结构类似物的含量,找出它们的质量差异。

方法

采用高效液相色谱法。分析了采集的9个样品中芍药苷和丹皮酚的含量,其中5个来自凤丹,4个来自牡丹,还分析了从不同地区购买的6个药材样品。研究了3种丹皮酚类似物和2种芍药苷类似物的大致含量。

结果与结论

  1. 凤丹和牡丹在丹皮酚和芍药苷含量以及其他主要成分组成上无明显差异。鉴于它们属于不同植物物种,建议凤丹和牡丹均应作为牡丹皮的来源载入《中国药典》。2. 丹皮酚的糖苷在药材采集和加工过程中可能会转化为丹皮酚。因此,当以丹皮酚含量作为评价药材和中成药质量的标准时,应注意上述转化情况。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验